Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis

Annals of Surgical Oncology

Volumn 9, Issue 9, 2002, Pages 901-906

  Sayed, M G ^a   Ahmed, A F ^a   Ringold, J R ^a   Anderson, M E ^a   Bair, J L ^a   Mitros, F A ^a   Lynch, H T ^b   Tinley, S T ^b   Petersen, G M ^c   Giardiello, F M ^d   Vogelstein, B ^d   Howe, J R ^a,e  

^a UNIVERSITY OF IOWA   (United States)

^b CREIGHTON UNIVERSITY   (United States)

^c MAYO CLINIC   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Hamartomatous polyps; Intestinal polyps; Juvenile polyposis; Polyposis syndromes

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; DNA; SMAD4 PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CANCER SUSCEPTIBILITY; CHILD; COLON POLYPOSIS; COLORECTAL CANCER; DNA EXTRACTION; EXON; FAMILIAL DISEASE; FAMILY HISTORY; GENE SEQUENCE; HUMAN; INTESTINE POLYP; JUVENILE POLYP; MAJOR CLINICAL STUDY; MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

EID: 0036842005     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02557528     Document Type: Article

References (38)

1. Jarvinen HJ, Franssila KO. Familial juvenile polyposis coli: Increased risk of colorectal cancer. Gut 1984;25:792-800.
2. Howe JR. Juvenile polyposis syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Vogelstein B, eds. The Metabolic and Molecular Bases of Inherited Disease. 8th Ed. New York: McGraw-Hill, 2001:805-18.
3. Jass JR, Williams CB, Bussey HJR, Morson BC. Juvenile polyposis - A precancerous condition. Histopathology 1988;13:619-30.
4. Subramony C, Scott-Conner CEH, Skelton D, Hall TJ. Familial juvenile polyposis. Study of a kindred: Evolution of polyps and relationship to gastrointestinal carcinoma. Am J Clin Pathol 1994; 102:91-7.
5. Nugent KP, Talbot IC, Hodgson SV, Phillips RK. Solitary juvenile polyps: Not a marker for subsequent malignancy. Gastroenterology 1993;105:698-700.
6. Burt RW, Bishop DT, Lynch HT, Rozen P, Winawer SJ. Risk and surveillance of individuals with heritable factors for colorectal cancer. Bull World Health Organ 1993;68:655-64.
7. Chevrel J-P, Amouroux J, Gueraud J-P. Trois cas familiaux de polypose juvenile. Chirurgie 1975;101:708-21.
8. Sachatello CR, Hahn IL, Carrington CB. Juvenile gastrointestinal polyposis in a female infant: Report of a case and review of the literature of a recently recognized syndrome. Surgery 1974;75:107-14.
9. Howe JR, Mitros FA, Summers RW. The risk of gastrointestinal carcinoma in familial juvenile polyposis. Ann Surg Oncol 1998;5:751-6.
10. Howe JR, Ringold JC, Summers RW, Mitros FA, Nishimura DY, Stone EM. A gene for familial juvenile polyposis maps to chromosome 18q21.1. Am J Hum Genet 1998;62:1129-36.
11. Howe JR, Roth S, Ringold JC, et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998;280:1086-8.
12. Roth S, Sistonen P, Salovaara R, et al. SMAD genes in juvenile polyposis. Genes Chromosomes Cancer 1999;26:54-61.
13. Friedl W, Kruse R, Uhlhaas S, et al. Frequent 4-bp deletion in exon 9 of the SMAD4/MADH4 gene in familial juvenile polyposis patients. Genes Chromosomes Cancer 1999;25:403-6.
14. Woodford-Richens K, Bevan S, Churchman M, et al. Analysis of genetic and phenotypic heterogeneity in juvenile polyposis. Gut 2000;46:656-60.
15. Kim IJ, Ku JL, Yoon KA, et al. Germline mutations of the dpc4 gene in Korean juvenile polyposis patients. Int J Cancer 2000;86:529-32.
16. Sayed MG, Bair JL, Anderson ME, et al. The frequency of SMAD4 and PTEN mutations in juvenile polyposis. Surg Forum 2001;52:230-1.
17. Heldin C-H, Miyazono K, Ten Dijke P. TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature 1997;390:465-71.
18. Howe JR, Bair JL, Sayed MG, et al. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 2001;28:184-7.
19. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from nucleated cells. Nucleic Acids Res 1988;16:1215.
20. Howe JR, Ringold JC, Hughes J, Summers RW. Direct genetic testing for Smad4 mutations in patients at risk for juvenile polyposis. Surgery 1999;126:162-70.
21. Howe JR, Karnell LH, Menck HR, Scott-Conner C. The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: Review of the National Cancer Data Base, 1985-1995. Cancer 1999;86:2693-706.
22. Haggitt RC, Reid BJ. Hereditary gastrointestinal polyposis syndromes. Am J Surg Pathol 1986;10:871-87.
23. Coburn MC, Pricolo VE, DeLuca FG, Bland KI. Malignant potential in intestinal juvenile polyposis syndromes. Ann Surg Oncol 1995;2:386-91.
24. Bussey HJ. Polyposis syndromes of the gastrointestinal tract. In: Sherlock P, Morson BC, Barbara L, Veronesi U, eds. Precancerous Lesions of the Gastrointestinal Tract. New York: Raven Press, 1983:43-52.
25. Hofting I, Pott G, Stolte M. Das Syndrom der Juvenilen Polyposis. Leber Magen Darm 1993;23:107-8.
26. Grosfeld JL, West KW. Generalized juvenile polyposis coli. Arch Surg 1986;121:530-4.
27. Murday V, Slack J. Inherited disorders associated with colorectal cancer. Cancer Surv 1989;8:139-57.
28. Schottenfeld D. Epidemiology. In: Cohen AM, Winawer SJ, eds. Cancer of the Colon, Rectum, and Anus. New York: McGraw-Hill, 1995:11-24.
29. Massague J. TGFβ signaling. Receptors, transducers, and Mad proteins. Cell 1996;85:947-50.
30. Wrana JL, Attisano L, Wieser R, Ventura F, Massague J. Mechanism of activation of the TGF-beta receptor. Nature 1994;370:341-7.
31. Shi Y, Hata A, Lo RS, Massague J, Pavletich NP. A structural basis for mutational inactivation of the tumor suppressor Smad4. Nature 1997;388:87-93.
32. Kawabata M, Inoue H, Hanyu A, Imamura T, Miyazono K. Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. EMBO J 1998;17:4056-65.
33. Liu F, Pouponnot C, Massague J. Dual role of the Smad4/DPC4 tumor suppressor in TGF-β-inducible transcriptional complexes. Genes Dev 1997;11:3157-67.
34. Takaku K, Miyoshi H, Matsunaga A, Oshima M, Sasaki N, Taketo MM. Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice. Cancer Res 1999;59:6113-7.
35. Sirard C, de la Pompa JL, Elia A, et al. The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev 1998;12:107-19.
36. Yang X, Li C, Xu X, Deng C. The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc Natl Acad Sci U S A 1998;95:3667-72.
37. Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin MF, Taketo MM. Intestinal tumorigenesis in compound mutant mice of both DPC4 (Smad4) and APC genes. Cell 1998;92:645-56.
38. Mishina Y, Suzuki A, Ueno N, Behringer RR. Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev 1995;9:3027-37.